We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
Division of Neurosurgery, University of British Columbia, Vancouver, BC, Canada
Celine Hounjet
Affiliation:
Division of Neurosurgery, University of British Columbia, Vancouver, BC, Canada
Alexander D. Rebchuk
Affiliation:
Division of Neurosurgery, University of British Columbia, Vancouver, BC, Canada
Jeremy Kam
Affiliation:
Department of Neurosurgery, Monash Health, Victoria, Australia
Nicolas Dea
Affiliation:
Division of Neurosurgery, University of British Columbia, Vancouver, BC, CanadaDepartment of Orthopedics, Spine Division, University of British Columbia, Vancouver, BC, Canada
Ian Mackenzie
Affiliation:
Department of Pathology and Laboratory Medicine, Division of Neuropathology, University of British Columbia, Vancouver, BC, Canada
Saba Vafaei-Nodeh
Affiliation:
Department of Pathology and Laboratory Medicine, Division of Neuropathology, University of British Columbia, Vancouver, BC, Canada
Ryojo Akagami
Affiliation:
Division of Neurosurgery, University of British Columbia, Vancouver, BC, Canada
Steven Yip
Affiliation:
Department of Pathology and Laboratory Medicine, Division of Neuropathology, University of British Columbia, Vancouver, BC, Canada
Mostafa Fatehi*
Affiliation:
Division of Neurosurgery, University of British Columbia, Vancouver, BC, Canada
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Article purchase
Temporarily unavailable
References
1
Guo, P, Wei, X, Guo, Z, Wu, D.Clinicopathological features, current status, and progress of primary central nervous system melanoma diagnosis and treatment. Pigment Cell Melanoma Res. 2024;37:265–275.Google Scholar
2
Lang-Orsini, M, Wu, J, Heilman, CB, et al. Primary meningeal melanoma masquerading as neurofibromatosis type 2: illustrative case. J Neurosurg: Case Lessons. 2021;2:1–6. doi: 10.3171/CASE21444.Google Scholar
3
Plotkin, SR, Messiaen, L, Legius, E, et al. Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation. Genet Med. 2022;24:1967–1977.Google Scholar
4
Suranagi, VV, Maste, P, Malur, PR.Primary intracranial malignant melanoma: a rare case with review of literature. Asian J Neurosurg. 2015;10:39–41.Google Scholar
5
Lewis, D, Dawson, TP, Hyde, R, et al. A rare case of multifocal craniospinal leptomeningeal melanocytoma: a case report and scoping review. Brain and Spine. 2024;4:102797.Google Scholar
6
Evans, DGR, Huson, SM, Donnai, D, et al. A clinical study of Type 2 neurofibromatosis. QJM: Int J Med. 1992;84:603–618.Google Scholar
7
Rosa Júnior, M, Da Motta, LL, Scardino, F.Primary meningeal melanoma with cerebrospinal fluid dissemination mimicking neurofibromatosis type 2. Arq Neuropsiquiatr. 2015;73:636–637.Google Scholar
8
Evans, DGR.Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis. 2009;4:1–11.Google Scholar